Who’s more to blame for dashed ‘scrip’ fills—insurers restricting drug coverage or prescribers failing to keep up?

July 13, 2026 - 02:58

Patients are increasingly finding that medications their doctors have prescribed never get filled, or arrive only after long delays. The growing problem has sparked a debate over who is more responsible: insurers that restrict drug coverage or prescribers who fail to keep up with changing requirements.

The issue centers on "scrip" fills, where a prescription is written but not dispensed. For patients, the result is the same: they wait for treatment or never receive it, even when a doctor has deemed the drug appropriate and timely.

Insurers argue they are not blocking access but managing costs and safety. They say many denials stem from prescribers not providing enough clinical information or failing to follow prior authorization steps. In their view, the system works when doctors submit complete paperwork.

Doctors push back, saying the burden has become unreasonable. They report spending hours on the phone with insurance companies, fighting for basic medications. Many say the process is so time-consuming that some prescriptions simply fall through the cracks. A physician might write a script, but if the insurer changes its formulary or requires a new step therapy protocol without clear notice, the patient never gets the drug.

The real loser in this standoff is the patient. People with chronic conditions like diabetes, heart disease, or mental health disorders often face the worst delays. Some skip doses, others end up in emergency rooms, and a few simply give up on treatment.

Neither side appears ready to concede. Insurers say they are open to streamlining processes if doctors use electronic prior authorization tools. Doctors say they would welcome that, but only if insurers stop changing rules midstream. Until then, patients remain caught in the middle.